NEW YORK-Rosen Law Firm, a global investor rights law firm, announces that a shareholder represents all purchases of Cassava between February 7, 2024, and November 24, 2024. Investors in Sciences, Inc. (NASDAQ: SAVA) securities filed a class action lawsuit. Cassava describes itself as a “clinical-stage biotechnology company focused on developing drugs to treat neurodegenerative diseases.”
For more information, please submit a form, email attorney Phillip Kim, or call us at 866-767-3653.
Allegations: Rosen Law Firm is investigating allegations that Cassava Sciences, Inc. (NASDAQ: SAVA) misled investors about its business operations.
The indictment alleges that the defendants created a false impression throughout the class action period, claiming to have reliable information about Cassava’s drug prospects and expected growth, while at the same time trying to downplay the risk of potential drug failure. But in fact, despite Cassava’s repeated statements of confidence in its drug and its reliance on statistically insignificant data gleaned from phase 2 studies, this is seriously at odds with the actual potential of Cassava’s lead drug candidate, simufilam; Cassava simply has no A drug can slow the progression of Alzheimer’s, even if it only tries to treat mild and moderate cases. The lawsuit alleges that when the market learned the true details, investors suffered losses.
What to do now: You may be eligible to participate in a class action lawsuit against Cassava Sciences, Inc. If a shareholder wishes to serve as a representative plaintiff in this class action, he or she must apply to the court before February 10, 2025. A representative plaintiff is a party representative who leads the litigation on behalf of other class members. You do not need to be involved in the case to be eligible for recovery. If you choose to take no action, you may also remain an absent class member. For more information, click here.
All agents are paid upon winning the case. There are no fees or expenses to be paid by shareholders.
About Rosen Law Firm: Unlike Rosen Law Firm, some of the law firms that make announcements on these matters do not actually file securities class action lawsuits. As a recognized leader in the field of shareholder rights litigation, Rosen Law Firm has been committed to assisting shareholders to recover losses, improve corporate governance structures, and hold company senior executives accountable for illegal acts. Since its inception, Rosen Law Firm has recovered more than $1 billion for shareholders.
Join us on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm , Twitter: https://twitter.com/rosen_firm or Facebook: https://www.facebook.com/rosenlawfirm/ Follow us on to stay informed.
Lawyer advertising. Previous cases do not guarantee a similar outcome.
Disclaimer: The original version of this announcement is the officially authorized version. The translation is for convenience of understanding only. Please refer to the original text. The original version is the only legally binding version.
Contacts
Laurence Rosen Attorney
Phillip Kim Attorney
The Rosen Law Firm, PA
275 Madison Avenue, 40th Floor
New York, NY 10016Phone
: (212) 686-1060Toll
Free: (866) 767-3653Fax
: (212) 202-3827
case@ rosenlegal.com
www.rosenlegal.com
